Wolverine Asset Management’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $176K | Sell |
500
-4,300
| -90% | -$1.53M | ﹤0.01% | 1101 |
|
|
2025
Q4 | $1.57M | Sell |
4,800
-200
| -4% | -$63.4K | 0.01% | 660 |
|
|
2025
Q3 | $1.41M | Buy |
5,000
+100
| +2% | +$29K | 0.01% | 655 |
|
|
2025
Q2 | $1.37M | Sell |
4,900
-1,500
| -23% | -$425K | 0.01% | 624 |
|
|
2025
Q1 | $1.99M | Sell |
6,400
-23,500
| -79% | -$6.94M | 0.02% | 518 |
|
|
2024
Q4 | $7.79M | Buy |
29,900
+700
| +2% | +$208K | 0.08% | 235 |
|
|
2024
Q3 | $9.41M | Buy |
29,200
+10,300
| +54% | +$3.37M | 0.1% | 201 |
|
|
2024
Q2 | $5.91M | Buy |
18,900
+3,300
| +21% | +$969K | 0.07% | 264 |
|
|
2024
Q1 | $4.44M | Sell |
15,600
-22,000
| -59% | -$6.44M | 0.05% | 309 |
|
|
2023
Q4 | $10.8M | Sell |
37,600
-200
| -0.5% | -$54.5K | 0.09% | 224 |
|
|
2023
Q3 | $10.2M | Sell |
37,800
-9,800
| -21% | -$2.45M | 0.11% | 197 |
|
|
2023
Q2 | $10.6M | Sell |
47,600
-800
| -2% | -$186K | 0.13% | 171 |
|
|
2023
Q1 | $11.7M | Buy |
48,400
+43,700
| +930% | +$10.7M | 0.14% | 183 |
|
|
2022
Q4 | $1.23M | Buy |
+4,700
| New | +$1.26M | 0.01% | 689 |
|
|
2018
Q1 | – | Sell |
-4,500
| Closed | -$782K | – | 1412 |
|
|
2017
Q4 | $782K | Hold |
4,500
| – | – | 0.01% | 791 |
|
|
2017
Q3 | $839K | Hold |
4,500
| – | – | 0.01% | 709 |
|
|
2017
Q2 | $775K | Buy |
+4,500
| New | +$732K | 0.01% | 676 |
|
|
2017
Q1 | – | Sell |
-4,100
| Closed | -$599K | – | 1171 |
|
|
2016
Q4 | $599K | Hold |
4,100
| – | – | 0.01% | 633 |
|
|
2016
Q3 | $683K | Hold |
4,100
| – | – | 0.01% | 640 |
|
|
2016
Q2 | $623K | Buy |
4,100
+4,059
| +9,900% | +$631K | 0.01% | 659 |
|
|
2016
Q1 | $8K | Sell |
41
-11
| -21% | -$1.63K | ﹤0.01% | 1084 |
|
|
2015
Q4 | $63K | Sell |
52
-3
| -5% | -$472 | ﹤0.01% | 1088 |
|
|
2015
Q3 | $31K | Sell |
55
-309
| -85% | -$48.7K | ﹤0.01% | 1380 |
|
|
2015
Q2 | $127K | Buy |
364
+290
| +392% | +$46.5K | ﹤0.01% | 1046 |
|
|
2015
Q1 | $161K | Buy |
+74
| New | +$11.7K | ﹤0.01% | 928 |
|
|
2014
Q4 | – | Sell |
-267
| Closed | -$735K | – | 2133 |
|
|
2014
Q3 | $735K | Buy |
+267
| New | +$34.9K | 0.02% | 568 |
|
|
2014
Q1 | – | Sell |
-189
| Closed | -$479K | – | 2370 |
|
|
2013
Q4 | $479K | Sell |
189
-66
| -26% | -$7.51K | 0.01% | 791 |
|
|
2013
Q3 | $621K | Sell |
255
-79
| -24% | -$8.57K | 0.01% | 692 |
|
|
2013
Q2 | $430K | Buy |
+334
| New | +$34.7K | 0.01% | 800 |
|
Other funds holding AMGN
VCM
VPM
Wolverine Asset Management's AMGN Position: Q4 2025 in Review
Wolverine Asset Management sold out of Amgen (AMGN) in Q4 2025, closing a stake of 3,141 shares — an estimated $996K sold.
Wolverine Asset Management first reported a position in AMGN in Q2 2013 and held it in 24 quarters. The position peaked at $58.9M in Q4 2017. 3,084 funds tracked by Wall St. Rank hold AMGN as of Q4 2025.
- Wolverine Asset Management reported no remaining Amgen position as of Q4 2025 after selling out during the quarter.
- Wolverine Asset Management sold 3,141 Amgen shares in Q4 2025, an estimated $996K.
- Wolverine Asset Management first reported a position in Amgen in Q2 2013 and held it in 24 quarters.
- Wolverine Asset Management's Amgen position peaked at $58.9M in Q4 2017.
- 3,084 funds tracked by Wall St. Rank held Amgen as of Q4 2025.
Based on Wolverine Asset Management's 13F filing for Q4 2025, filed 2 Feb 2026.